Both type 1 and type 2 diabetes can be treated and managed with healthy eating, physical activity, and taking medications such as insulin to control blood glucose levels. Yale is also conducting research to develop new treatments as well as prevent diabetes in those at risk.
In 1979 Dr. Robert Sherwin and Dr. William Tamborlane developed the insulin pump to treat type 1 diabetes. Today it’s used by more than 350,000 patients. Without volunteers like the children and their families who were willing to participate in clinical research, this groundbreaking discovery would not have been possible.
When you take care of your diabetes, you’ll feel better. You’ll reduce your risk for problems with your kidneys, eyes, nerves, feet and legs, and teeth. You’ll also lower your risk for a heart attack or a stroke. Your doctor may prescribe medication, but you can also take care of your diabetes by being physically active and following a healthy meal plan.
When Hannah Rosenfield was diagnosed with Type 1 diabetes at age 10, her mother Amy immediately looked beyond the standard treatment for something that might benefit her daughter long term.
Dr. Gerald Shulman is working to uncover what happens in cells that leads to insulin resistance, which is at the core of type 2 diabetes. His research is pointing to new drug targets as well as exercise and dietary strategies that may lead to the reversal of insulin resistance and the prevention of type 2 diabetes.
Upcoming Diabetes Trial
A study comparing the effectiveness of three different classes of medications in patients already taking Metformin for Type 2 diabetes. Please check back in November for details.
Diabetes & Related Research Trials
- Diseases of the Nervous SystemImaging dopamine mediated effects of stress on inhibitory controlPrincipal Investigator: Evan Morris
- Mental Health & Behavioral ResearchA Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label ExtensionPrincipal Investigator: Roger J. Jou
- Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum, Diseases of the Kidney & Urinary TractEvaluate ALLN-177 in Patients With Enteric HyperoxaluriaPrincipal Investigator: Neera Dahl
- Esophagus, Kidney, Melanoma, skin, Pancreas, Stomach, Phase I, CervixA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of KY1044 as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesPrincipal Investigator: Joseph Paul Eder
- ProstateMultiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate CancerPrincipal Investigator: Jeffrey Weinreb